B. Riley Financial Varied
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

TherapeuticsMD, Inc. - Common Stock (NQ:TXMD)

2.334 +0.094 (+4.20%)
Streaming Delayed Price Updated: 9:48 AM EST, Jan 16, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about TherapeuticsMD, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
News headline image
TherapeuticsMD Announces Second Quarter 2021 Financial Results
From TherapeuticsMD, Inc.
Via Business Wire
News headline image
TherapeuticsMD to Report Second Quarter 2021 Results on August 4, 2021
From TherapeuticsMD, Inc.
Via Business Wire
News headline image
28 Stocks Moving in Friday's Pre-Market Session ↗
Gainers Toughbuilt Industries Inc (NASDAQ: TBLT) shares rose 61% to $1.16 in pre-market trading after the company reported 1H sales through Amazon of $5.48 million, up 118% year... 
Via Benzinga
News headline image
Earnings Scheduled For May 6, 2021 ↗
Companies Reporting Before The Bell • ViacomCBS (NASDAQ:VIAC) is projected to report quarterly earnings at $1.22 per share on revenue of $7.30 billion. • Cohen... 
Via Benzinga
News headline image
Earnings Scheduled For August 4, 2021 ↗
Companies Reporting Before The Bell • UroGen Pharma (NASDAQ:URGN) is projected to report earnings for its second quarter. • Vericel (NASDAQ:VCEL) is expected to... 
Via Benzinga
News headline image
The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs ↗
Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies. Most pharma majors reported strong quarterly results.... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive Preannouncement, European Nod For Myovant, HCW Biologics Debuts On Wall Street ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 19) Cytokinetics, Incorporated... 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Monday ↗
Stocks That Hit 52-Week Lows On Monday Monday morning, 285 companies reached new 52-week lows. Noteworthy Points: The largest company by market cap to set a new 52-week... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
Gainers Enzo Biochem (NYSE:ENZ) stock increa... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
Gainers Zosano Pharma (NASDAQ:ZSAN) stock... 
Via Benzinga
News headline image
TherapeuticsMD Announces Submission of Low Dose BIJUVA® 0.5 mg/100 mg Supplemental New Drug Application to FDA
From TherapeuticsMD, Inc.
Via Business Wire
News headline image
The Sun Sentinel Names TherapeuticsMD, Inc. a Winner of the South Florida Top Workplaces 2021 Award
From TherapeuticsMD, Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
Gainers Enveric Biosciences (NASDAQ:ENVB) stock rose 16.87% to $2.84 during Friday's pre-market session. The company's, Q1 earnings came out 3 days ago.... 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Tuesday ↗
Before 10 a.m. ET Tuesday, 173 stocks hit new 52-week lows. Intriguing Points: The largest company by market cap to set a new 52-week low was Snowflake (NYSE:SNOW... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 11) HOOKIPA Pharma Inc. (NASDAQ... 
Via Benzinga
News headline image
TherapeuticsMD, Inc. (TXMD) Q1 2021 Earnings Call Transcript ↗
TXMD earnings call for the period ending March 31, 2021. 
Via The Motley Fool
Topics Earnings
News headline image
TherapeuticsMD Shares Plunge On Declining Gross Margin, Total Prescription Volume ↗
TherapeuticsMD Inc (NASDAQ: TXMD) reported a Q1 EPS loss of $0.11 better than the analyst consensus estimate loss of $0.12, as well as an improvement from EPS... 
Via Benzinga
News headline image
TherapeuticsMD Announces First Quarter 2021 Financial Results
From TherapeuticsMD, Inc.
Via Business Wire
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
Gainers Applied Genetic (NASDAQ:AGTC) sha... 
Via Benzinga
News headline image
TherapeuticsMD Announces Poster Presentation of ANNOVERA® Data at the American College of Obstetricians and Gynecologists 2021 Annual Meeting
From TherapeuticsMD, Inc.
Via Business Wire
News headline image
TherapeuticsMD to Report First Quarter 2021 Results on May 6, 2021
From TherapeuticsMD, Inc.
Via Business Wire
News headline image
TXMD Stock: The News Giving TherapeuticsMD Shares a Shot in the Arm Friday ↗
TherapeuticsMD (TXMD) stock is up on Friday after announcing approval for one of its hormone treatments in two parts of Europe. 
Via InvestorPlace
News headline image
The Daily Biotech Pulse: Negative Regulatory Tidings For Provention Bio, Celcuity Soars On In-licensing Deal, 2 IPOs ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 8) Aclaris Therapeutics, Inc... 
Via Benzinga
News headline image
30 Stocks Moving in Friday's Pre-Market Session ↗
Gainers Celcuity Inc. (NASDAQ: CELC) rose 32.3% to $19.00 in pre-market trading after the company reported a worldwide licensing agreement with Pfizer to develop and... 
Via Benzinga
News headline image
10 Stocks Moving In Thursday's After-Hours Session ↗
Gainers FuboTV (NYSE: FUBO) shares are trading higher after the company announced it acquired exclusive streaming rights to the Qatar World Cup 2022 Qualifying matches of South... 
Via Benzinga
News headline image
TherapeuticsMD and Theramex Announce the Approval of BIJUVE® Capsules Indicated for Hormone Replacement Therapy in the United Kingdom and Under the Trade Name BIJUVA® in Belgium
From TherapeuticsMD, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
B. Riley Financial's diverse suite of services goes beyond traditional financial service offerings. By leveraging cross-platform expertise and assets, B. Riley Financial companies are uniquely positioned to provide full service, collaborative solutions to our clients at every stage of the business life cycle and in all market conditions.

B. Riley refers to B. Riley Financial, Inc. and/or one or more of its subsidiaries or affiliates. Click here for further details.